Endologix to Host Investor Meeting on October 2, 2018
August 23 2018 - 8:00AM
Business Wire
Endologix, Inc. (Nasdaq:ELGX) (“Endologix” or the “Company”), a
developer and marketer of innovative treatments for aortic
disorders, today announced that it will host a meeting for
financial analysts and investment professionals at 4:15 p.m. ET on
Tuesday, October 2, 2018, at The London Hotel NYC, 151 W. 54th St.,
New York, NY 10019.
The preliminary agenda for the event
includes:
4:15 p.m. – 6:00 p.m. ET
Management strategic and financial presentations, physician
presentations, Q&A 6:00 p.m. – 7:00 p.m. ET Product showcase of
Endologix devices
Participants may register for the meeting
here.
For those unable to attend in person, a live webcast of the
presentations will begin at 4:15 p.m. ET, and will be available on
the “Investors” section of the Company’s website at www.endologix.com. Following the event, a replay
of the presentation and the associated materials will be available
on the same site.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's focus is
endovascular stent grafts for the treatment of abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
80%, making it a leading cause of death in the United States. For
more information, visit www.endologix.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180823005178/en/
Endologix, Inc.InvestorsVaseem Mahboob, 949-595-7200CFO
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Apr 2023 to Apr 2024